Ischaemia-Driven Optimal Therapeutic Approach in Asymptomatic Patients with High Cardiovascular Risk: The Value of Clinical, Laboratory and Myocardial Spect Imaging Findings
暂无分享,去创建一个
M. Bosevski | I. Mitevska | J. Pavlovska | M. Zdravkovska | E. Srbinovska | M. Zdravevska | D. P. Gorceva
[1] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[2] G. Beller,et al. Stress myocardial perfusion imaging for assessing prognosis: an update. , 2011, JACC. Cardiovascular imaging.
[3] Erling Falk,et al. Why not screen for subclinical atherosclerosis? , 2011, The Lancet.
[4] M. Budoff,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[5] P. Shah. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? , 2010, Journal of the American College of Cardiology.
[6] V. Fuster,et al. The CVD paradox: mortality vs prevalence , 2009, Nature Reviews Cardiology.
[7] Jeroen J. Bax,et al. Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: implications for expanded use of myocardial perfusion imaging , 2005 .
[8] M. D. Di Carli,et al. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? , 2005, Journal of the American College of Cardiology.
[9] R. Gibbons,et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. , 2005, Journal of the American College of Cardiology.
[10] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[11] R. Gibbons,et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. , 2004, American heart journal.
[12] D. Berman,et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. , 2004, European heart journal.
[13] L. Shaw,et al. Prognostic value of gated myocardial perfusion SPECT , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[14] A. Siqueira-Filho,et al. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. , 2002, The American journal of cardiology.
[15] D. Berman,et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. , 1999, American heart journal.
[16] L. Shaw,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[17] R. Ferrari,et al. Cardiovascular Disease Prevention in Clinical Practice , 2010 .
[18] S. Abraham,et al. 22. Observer variation in electrocardiographic interpretation , 1964 .